Loading clinical trials...
Loading clinical trials...
A 24-hour Ambulatory Blood Pressure Monitoring Study in Hypogonadal Men Treated With Natesto Nasal Testosterone Gel
Conditions
Interventions
Natesto
Locations
30
United States
Alabama Clinical Therapeutics
Birmingham, Alabama, United States
Horizon Clinical Research Associates
Phoenix, Arizona, United States
Eclipse Clinical Research
Tucson, Arizona, United States
Preferred Research Partners
Little Rock, Arkansas, United States
Valley Clinical Trials
Northridge, California, United States
Lynn Institute of the Rockies
Colorado Springs, Colorado, United States
Start Date
July 1, 2021
Primary Completion Date
December 1, 2022
Completion Date
December 1, 2022
Last Updated
July 6, 2022
NCT06019182
NCT06689085
NCT06841328
NCT03851627
NCT06094036
NCT06691815
Lead Sponsor
Acerus Pharmaceuticals Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions